NCT00092599View on ClinicalTrials.gov

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

PHASE3CompletedINTERVENTIONAL

Enrollment

410

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

July 31, 2004

Conditions

HypercholesterolemiaCoronary Disease

Interventions

DRUG

MK0653, ezetimibe

DRUG

Comparator: ezetimibe, placebo

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092599 - Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801) | Biotech Hunter | Biotech Hunter